High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples